Skip to Main Content

Author Details

Peter S Nelson
Fred Hutchinson Cancer Center
1993
432
96
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37850574Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.J Pathol2024
37850574Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.J Pathol2024
37796107Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.Prostate2024
37796107Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.Prostate2024
36821396Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.JCI Insight2023
36399432Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.Cancer Discov2023
37823778Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.Cancer Res Commun2023
37905039ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.bioRxiv2023
37725435Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.J Clin Invest2023
37577653Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.bioRxiv2023
37559436Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer.Prostate2023
38072760Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.Eur Urol Oncol2023
38049604Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment.Nat Cell Biol2023
36779357Clinical, pathologic, and molecular features of amphicrine prostate cancer.Prostate2023
37343766Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.Mod Pathol2023
36650259The future of patient-derived xenografts in prostate cancer research.Nat Rev Urol2023
36710146A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.Clin Genitourin Cancer2023
37333335A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.bioRxiv2023
36821396Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.JCI Insight2023
36564459Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer.Prostate Cancer Prostatic Dis2023
36697405Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.Nat Commun2023
36623239Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.JCO Precis Oncol2023
37440313LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.JCI Insight2023
36621992Reply by Authors.J Urol2023
36621991Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.J Urol2023
36993558Analysis of evolutionary dynamics and clonal architecture in prostate cancer.bioRxiv2023
37352376Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.Cancer Res2023
37041154Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.Nat Commun2023
37533407Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities.Mol Oncol2023
37559436Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer.Prostate2023
38072760Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.Eur Urol Oncol2023
37905039ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.bioRxiv2023
38049604Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment.Nat Cell Biol2023
37577653Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.bioRxiv2023
37823778Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.Cancer Res Commun2023
37725435Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.J Clin Invest2023
37533407Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities.Mol Oncol2023
36993558Analysis of evolutionary dynamics and clonal architecture in prostate cancer.bioRxiv2023
37352376Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.Cancer Res2023
37343766Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.Mod Pathol2023
37041154Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.Nat Commun2023
37440313LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.JCI Insight2023
37333335A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.bioRxiv2023
36697405Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.Nat Commun2023
36623239Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.JCO Precis Oncol2023
36621992Reply by Authors.J Urol2023
36621991Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.J Urol2023
36650259The future of patient-derived xenografts in prostate cancer research.Nat Rev Urol2023
36779357Clinical, pathologic, and molecular features of amphicrine prostate cancer.Prostate2023
36399432Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.Cancer Discov2023
  • 1 - 50 of 864

Recommended Authors

Natalie Kurganovs
Australian Prostate Cancer Research Centre Epworth
Career Start Year 2015
Number of shared co-authors 3
Richard J Rebello
University of Melbourne
Career Start Year 2015
Number of shared co-authors 10
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 39
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 18
Estelle Li
University of British Columbia
Career Start Year 2012
Number of shared co-authors 20
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 50
Alec Paschalis
The Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 17
Douglas W Strand
University of Texas Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 7
Alastair Davies
University of British Columbia
Career Start Year 2008
Number of shared co-authors 17
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 34
Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 34
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 21
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 57
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 29
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 17
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 20
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 37
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 67
Mark C Markowski
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Career Start Year 2001
Number of shared co-authors 20
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 42
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 15
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 5
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 20
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 32
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 16
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 33
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 19
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 6
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 39
Ralph Buttyan
University of British Columbia
Career Start Year 1976
Number of shared co-authors 24

Collaborators

Ilsa Coleman
Fred Hutchinson Cancer Center
Co-authored papers 132
Lawrence D True
University of Washington School of Medicine
Co-authored papers 92
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 76
Colm Morrissey
Co-authored papers 70
Daniel W Lin
Co-authored papers 66
Eva Corey
University of Washington School of Medicine
Co-authored papers 65
Elahe A Mostaghel
University of Washington
Co-authored papers 61
Robert L Vessella
University of Washington
Co-authored papers 57
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 45
Martin E Gleave
University of British Columbia
Co-authored papers 42
Stephen R Plymate
University of Washington
Co-authored papers 41
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 32
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 28
Mary-Ellen Taplin
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 26
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 25
Celestia S Higano
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 23
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Co-authored papers 22
Steven P Balk
Beth Israel Deaconess Medical Center and Harvard Medical School
Co-authored papers 22
Michael C Haffner
Fred Hutchinson Cancer Center
Co-authored papers 21
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 20
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
Ladan Fazli
University of British Columbia
Co-authored papers 18
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 18
Mark A Rubin
University of Bern
Co-authored papers 17
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 17
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 16
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 15
Dean A Troyer
Eastern Virginia Medical School
Co-authored papers 15
Alvin M Matsumoto
Co-authored papers 15
Camari Ferguson
Co-authored papers 14
Release 1.2